[Possibility of selective nonspecific suppression of immune reactions].
D000707:Anaphylaxis / Q000188:drug therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002701:Chloramphenicol / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology; D005938:Glucocorticoids / Q000627:therapeutic use; D006967:Hypersensitivity / Q000188:drug therapy; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use / Q000633:toxicity; D009150:Mustard Compounds / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy; D011687:Purines / Q000037:antagonists & inhibitors; D013276:Stomach Ulcer / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy
D000961:Antilymphocyte Serum; D005493:Folic Acid Antagonists; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D009150:Mustard Compounds; D011687:Purines; D003561:Cytarabine; D002701:Chloramphenicol
K vozmozhnosti izbiratelnogo nespetsificheskogo ugneteniia reaktsiĭ immuniteta